The Patent Finder

Theravida, Inc.

Also on record
Records under this name other than the patents Theravida, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.

Showing 1 to 6 of 6 · Back to Theravida, Inc.

PatentTitleStatus Expires Confidence
US 7,666,894Therapy for the treatment of disease
Term ended
Term ended Aug 28, 2026 · From the USPTO record
Term endedTerm ended Aug 28, 2026From the USPTO record
US 8,470,864Compositions and methods for the treatment of overactive bladder
Term ended
Ended no later than Aug 28, 2026 · From the USPTO record
Term endedEnded no later than Aug 28, 2026From the USPTO record
US 9,132,124Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
Lapsed on the fee record
Ended Sep 15, 2023 · From the USPTO record
Lapsed on the fee recordEnded Sep 15, 2023From the USPTO record
US 8,940,763Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
Lapsed on the fee record
Ended Jan 27, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jan 27, 2023From the USPTO record
US 7,781,472Therapy for the treatment of disease
Lapsed on the fee record
Ended Aug 24, 2022 · From the USPTO record
Lapsed on the fee recordEnded Aug 24, 2022From the USPTO record
US 9,744,157Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
Lapsed on the fee record
Ended Aug 29, 2021 · From the USPTO record
Lapsed on the fee recordEnded Aug 29, 2021From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited